Skip to main content
profile image
Selected Works of Walter J. Urba, MD, PhD
Article
An exploratory study of the biologic effects of nivolumab (Anti-PD-1; BMS-936558; ONO-4538) treatment in patients (pts) with advanced (unresectable or metastatic) melanoma (MEL).
Journal of Clinical Oncology (2013)
  • Jeffrey Alan Sosman, Vanderbilt University
  • Salvador Martin-Algarra, University of Navarra
  • Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center
  • William Howard Sharfman, Johns Hopkins University
  • Shailender Bhatia, University of Washington
  • F. Stephen Hodi, Cancer Institute
  • Wen-Jen Hwu, University of Texas MD Anderson Cancer Center
  • Thomas Gajewski, University of Chicago
  • Craig L. Slingluff, University of Virginia Health System
  • Howard Kaufman, Yeshiva University
  • Manish Gupta, Genentech
  • Analia McGirr
  • Christine E. Horak, Bristol-Myers Squibb
  • Christoph Matthias Ahlers, Bristol-Myers Squibb
  • Jon M. Wigginton, Bristol-Myers Squibb
  • Walter John Urba
Link
Disciplines
Publication Date
May 20, 2013
Citation Information
Jeffrey Alan Sosman, Salvador Martin-Algarra, Jedd D. Wolchok, William Howard Sharfman, et al.. "An exploratory study of the biologic effects of nivolumab (Anti-PD-1; BMS-936558; ONO-4538) treatment in patients (pts) with advanced (unresectable or metastatic) melanoma (MEL)." Journal of Clinical Oncology Vol. 31 (2013)
Available at: http://works.bepress.com/walter-urba/141/